Ketoprofene Sale Di Lisina Sandoz Gmbh

Ketoprofen, the active ingredient in Ketoprofene Sale Di Lisina Sandoz Gmbh, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for oral use. It treats pain and inflammation in adults, helping to relieve symptoms of musculoskeletal disorders and acute painful conditions.

GNH USA supplies Ketoprofene Sale Di Lisina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Ketoprofen is an NSAID used to manage pain and inflammation associated with musculoskeletal and inflammatory conditions.

Rheumatoid arthritis: reduces joint pain, swelling and stiffness. Osteoarthritis: alleviates chronic joint discomfort and improves mobility. Acute pain: provides relief for postoperative, dental or musculoskeletal pain. Ankylosing spondylitis: diminishes spinal inflammation and associated pain.

Ketoprofen may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Gastrointestinal discomfort such as nausea, dyspepsia or abdominal pain. - Headache or dizziness. - Mild skin rash or itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe hypersensitivity reactions, including Stevens‑Johnson syndrome. - Renal impairment or sudden loss of kidney function. - Elevated liver enzymes indicating hepatic injury.

Ketoprofen should be used with caution in specific clinical situations.

Cardiovascular risk: avoid in patients with uncontrolled hypertension or recent myocardial infarction. Gastrointestinal safety: use gastro‑protective agents in patients with a history of ulcers. Renal function: monitor kidney parameters in those with pre‑existing renal disease. Pregnancy and lactation: assess risk‑benefit before prescribing to pregnant or nursing women. Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Ketoprofen can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, especially in volume‑depleted patients. - Lithium: NSAIDs can raise lithium serum levels, risking toxicity. - Methotrexate: reduced clearance may lead to enhanced toxicity.